DOI: 10.1111/apt.16299 ISSN:

Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test

Raoel Maan, Milan J. Sonneveld
  • Pharmacology (medical)
  • Gastroenterology
  • Hepatology

LINKED CONTENT

This article is linked to Fallahzadeh et al and Asrani & Everson papers. To view these articles, visit https://doi.org/10.1111/apt.16283 and https://doi.org/10.1111/apt.16311

More from our Archive